How to buy Sorrento Therape stock (SRNE)

Sorrento Therape is a biotechnology business based in the US. Sorrento Therape shares (SRNE) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.00 – a decrease of 20% over the previous week. Sorrento Therape employs 949 staff and has a trailing 12-month revenue of around $64.3 million.

Our top picks for where to buy Sorrento Therape stock

Buy Sorrento Therape stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Sorrento Therape stock price (OTCQB: SRNE)

Use our graph to track the performance of SRNE stocks over time.

Sorrento Therape shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.00
52-week range	$0.00 - $0.25
50-day moving average more info button	$0.00
200-day moving average more info button	$0.01
Wall St. target price	$13.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.10

Is it a good time to buy Sorrento Therape stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sorrento Therape price performance over time

Historical closes compared with the close of $0.0014 from 2024-12-18

1 week (2024-12-12)	27.27%
1 month (2024-11-20)	-57.58%
3 months (2024-09-19)	-75.00%
6 months (2024-06-18)	-89.63%

1 year (2023-12-19)	-94.98%
2 years (2022-12-19)	-99.84%
3 years (2021-12-17)	6.1
5 years (2019-12-19)	3.66

Sorrento Therape financials

Revenue TTM	$64.3 million
Gross profit TTM	$-167,049,000
Return on assets TTM	-40.82%
Return on equity TTM	-378.92%
Profit margin	0%
Book value	$-0.38
Market Capitalization more info button	$771,793

TTM: trailing 12 months

Sorrento Therape share dividends

We're not expecting Sorrento Therape to pay a dividend over the next 12 months.

Have Sorrento Therape's shares ever split?

Sorrento Therape's shares were split on a 1:25 basis on 31 July 2013 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sorrento Therape shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Sorrento Therape shares which in turn could have impacted Sorrento Therape's share price.

Sorrento Therape share price volatility

Over the last 12 months, Sorrento Therape's shares have ranged in value from as little as $0.0001 up to $0.2495. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Sorrento Therape's is 1.835. This would suggest that Sorrento Therape's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Sorrento Therape overview

Sorrento Therapeutics, Inc. , a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis pain treatment; and ZTlido, a lidocaine topical system for the treatment of post-herpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia.

Frequently asked questions

null
What percentage of Sorrento Therape is owned by insiders or institutions?
Currently 0.89% of Sorrento Therape shares are held by insiders and 0.039% by institutions. How many people work for Sorrento Therape?
Latest data suggests 949 work at Sorrento Therape. When does the fiscal year end for Sorrento Therape?
Sorrento Therape's fiscal year ends in December. Where is Sorrento Therape based?
Sorrento Therape's address is: 4955 Directors Place, San Diego, CA, United States, 92121 What is Sorrento Therape's ISIN number?
Sorrento Therape's international securities identification number is: US83587F2020 What is Sorrento Therape's CUSIP number?
Sorrento Therape's Committee on Uniform Securities Identification Procedures number is: 74838K306